| For: | Cao Y, Shu XB, Yao Z, Ji G, Zhang L. Is vitamin D receptor a druggable target for non-alcoholic steatohepatitis? World J Gastroenterol 2020; 26(38): 5812-5821 [PMID: 33132636 DOI: 10.3748/wjg.v26.i38.5812] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v26/i38/5812.htm |
| Number | Citing Articles |
| 1 |
炟欣 朱. Vitamin D and Cardiovascular Disease: A Comprehensive Evaluation of Mechanisms, Epidemiological Evidence, and Clinical Therapies. Advances in Clinical Medicine 2026; 16(07) doi: 10.12677/acm.2026.1672704
|
| 2 |
Rose Anne M Abe, Anum Masroor, Arseni Khorochkov, Jose Prieto, Karan B Singh, Maduka C Nnadozie, Muhammad Abdal, Niki Shrestha, Lubna Mohammed. The Role of Vitamins in Non-Alcoholic Fatty Liver Disease: A Systematic Review. Cureus 2021; doi: 10.7759/cureus.16855
|
| 3 |
Ting Hong, Yiyan Chen, Xiaoying Li, Yan Lu, Jun Pu. The Role and Mechanism of Oxidative Stress and Nuclear Receptors in the Development of NAFLD. Oxidative Medicine and Cellular Longevity 2021; 2021(1) doi: 10.1155/2021/6889533
|
| 4 |
Navya Malladi, Devidas Lahamge, Balaji Sanjay Somwanshi, Vikas Tiwari, Kajal Deshmukh, Jagdish Kumar Balani, Samhita Chakraborty, Md Jahangir Alam, Sanjay K. Banerjee. Paricalcitol attenuates oxidative stress and inflammatory response in the liver of NAFLD rats by regulating FOXO3a and NFκB acetylation. Cellular Signalling 2024; 121 doi: 10.1016/j.cellsig.2024.111299
|
| 5 |
Chun-Xiao Li, Yi Chen, Jun-Zhuo Wang, Kang-Peng Zhong, Ting Gao. Allyl isothiocyanate ameliorates metabolic dysfunction-associated steatotic liver disease <i>via</i> vitamin D receptors in hepatocytes. World Journal of Gastroenterology 2026; 32(4): 113647 doi: 10.3748/wjg.v32.i4.113647
Abstract(83) |
Core Tip(86) |
Full Article(HTML)(373)
|
Full Article (PDF)-8113K(175)
|
Full Article with Cover (PDF)-8436K(49)
|
Full Article (XML)-133K(62)
|
Audio-382K(15)
|
Peer-Review Report-192K(40)
|
Answering Reviewers-417K(45)
|
Supplementary Material-91K(36)
|
Times Cited (1)
|
Total Visits (761)
|
Open
|
| 6 |
Ioanna Aggeletopoulou, Efthymios P. Tsounis, Christos Triantos. Vitamin D and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Novel Mechanistic Insights. International Journal of Molecular Sciences 2024; 25(9) doi: 10.3390/ijms25094901
|
| 7 |
Ashok Kumar Sekar, Anthony Josephine, Jayavelu Tamilselvan, Varalakshmi Sureka, Peramaiyan Rajendran, Meivelu Moovendhan. Dysregulation and gene polymorphisms of Vitamin D receptor: its implications in lipid metabolic disorders. Molecular Biology Reports 2025; 52(1) doi: 10.1007/s11033-025-10725-7
|
| 8 |
Shriram Mahajan, Navya Malladi, Sanjay K. Banerjee. Future potential therapeutics to treat MASH. Drug Discovery Today 2025; 30(9) doi: 10.1016/j.drudis.2025.104451
|
| 9 |
Kota Kurosaki, Yoshihiro Uesawa. Molecular Initiating Events Associated with Drug-Induced Liver Malignant Tumors: An Integrated Study of the FDA Adverse Event Reporting System and Toxicity Predictions. Biomolecules 2021; 11(7) doi: 10.3390/biom11070944
|
| 10 |
Mauro Giuffrè, Nicola Merli, Maura Pugliatti, Rita Moretti. The Metabolic Impact of Nonalcoholic Fatty Liver Disease on Cognitive Dysfunction: A Comprehensive Clinical and Pathophysiological Review. International Journal of Molecular Sciences 2024; 25(6) doi: 10.3390/ijms25063337
|
| 11 |
Basma A. Abdelrahman, Olfat A. Hammam, Aiman S. El-Khatib, Yasmeen M. Attia. The role of vitamin D3 in modulating the interplay between NLRP3 inflammasome and autophagy in NASH. Biochemical and Biophysical Research Communications 2023; 688 doi: 10.1016/j.bbrc.2023.149122
|
| 12 |
Jian-Ji Dai, Yi Deng, Guo-Feng Wang, Kai-Qin Lin, Jian-Rong He, Xiao-Gang Hu. Relationship of serum 25(OH)D3 and PTX3 with liver fat content in patients with non-alcoholic fatty liver disease: Diagnostic value for liver fibrosis. World Chinese Journal of Digestology 2025; 33(3) doi: 10.11569/wcjd.v33.i3.192
Abstract(501) |
Core Tip(444) |
Full Article(HTML)(1173)
|
Times Cited (0)
|
Total Visits (1741)
|
Open
|
| 13 |
XiangFen Chen, Sheng Qiu, Juan Jiang, QiNan Wu. Beyond bones, vitamin D as a sunshine hormone in type 2 diabetes mellitus and its complications. iScience 2026; 29(3) doi: 10.1016/j.isci.2026.115153
|
| 14 |
Federico Carbone, Jean‐Pierre Després, John P. A. Ioannidis, Ian J. Neeland, Gabriella Garruti, Luca Busetto, Luca Liberale, Stefano Ministrini, Gemma Vilahur, Thomas H. Schindler, Maria Paula Macedo, Agostino Di Ciaula, Marcin Krawczyk, Andreas Geier, Gyorgy Baffy, Maria Felicia Faienza, Ilaria Farella, Nicola Santoro, Gema Frühbeck, Patricia Yárnoz‐Esquiroz, Javier Gómez‐Ambrosi, Emma Chávez‐Manzanera, Verónica Vázquez‐Velázquez, Jean‐Michel Oppert, Dimitrios N. Kiortsis, Paolo Sbraccia, Carmine Zoccali, Piero Portincasa, Fabrizio Montecucco. Bridging the gap in obesity research: A consensus statement from the European Society for Clinical Investigation. European Journal of Clinical Investigation 2025; 55(8) doi: 10.1111/eci.70059
|
| 15 |
Jacek Pietruszkiewicz, Katarzyna Mrozek, Mateusz Zwierz, Agata Wińska, Maria Suprunowicz, Aleksandra Julia Oracz, Napoleon Waszkiewicz. The Neuroprotective Potential of Vitamin D3. Nutrients 2025; 17(20) doi: 10.3390/nu17203202
|
| 16 |
Jingqi Liu, Yang Song, Ye Wang, Huashan Hong. Vitamin D/vitamin D receptor pathway in non-alcoholic fatty liver disease. Expert Opinion on Therapeutic Targets 2023; 27(11) doi: 10.1080/14728222.2023.2274099
|
| 17 |
Abhishek Yadav, Ambuj Shahi, Rohit A. Sinha, Sushmita Singh, Pratik Medhe, Mable M. Singh, Amit Goel. MASH associated lipotoxicity perturbs the expression of hepatic vitamin D bioactivating gene CYP2R1 in humans and mice. Biochemical and Biophysical Research Communications 2026; 820 doi: 10.1016/j.bbrc.2026.153865
|
| 18 |
Ling Wang, Hongzhao Lu, Shanshan Wang, Huan Liu, Miaomiao Guo, Hao Bai, Wenxian Zeng, Tao Zhang. Vitamin D Receptor affects male mouse fertility via regulation of lipid metabolism and testosterone biosynthesis in testis. Gene 2022; 834 doi: 10.1016/j.gene.2022.146589
|
| 19 |
Xin Guo, Mei Zhang, Mengjun Xie. Research progress on the prevention and treatment of diseases with traditional Chinese medicine: A focus on BA receptors. The Journal of Steroid Biochemistry and Molecular Biology 2026; 256 doi: 10.1016/j.jsbmb.2025.106906
|
| 20 |
Paloma Sangro, Manuel de la Torre Aláez, Bruno Sangro, Delia D’Avola. Metabolic dysfunction–associated fatty liver disease (MAFLD): an update of the recent advances in pharmacological treatment. Journal of Physiology and Biochemistry 2023; 79(4) doi: 10.1007/s13105-023-00954-4
|
| 21 |
Basma A. Abdelrahman, Aiman S. El-Khatib, Yasmeen M. Attia. Insights into the role of vitamin D in targeting the culprits of non-alcoholic fatty liver disease. Life Sciences 2023; 332 doi: 10.1016/j.lfs.2023.122124
|
| 22 |
Piero Portincasa, Mohamad Khalil, Laura Mahdi, Valeria Perniola, Valeria Idone, Annarita Graziani, Gyorgy Baffy, Agostino Di Ciaula. Metabolic Dysfunction–Associated Steatotic Liver Disease: From Pathogenesis to Current Therapeutic Options. International Journal of Molecular Sciences 2024; 25(11) doi: 10.3390/ijms25115640
|
| 23 |
Ricardo Amorim, Pedro Soares, Daniel Chavarria, Sofia Benfeito, Fernando Cagide, José Teixeira, Paulo J. Oliveira, Fernanda Borges. Decreasing the burden of non-alcoholic fatty liver disease: From therapeutic targets to drug discovery opportunities. European Journal of Medicinal Chemistry 2024; 277 doi: 10.1016/j.ejmech.2024.116723
|